pfizer glp 1 oral GLP-1 Danuglipron Dropped After 73% Nausea and One Liver Injury Case Among 1,400 Patients Pfizer Licenses YP05002, a Small-Molecule

Description

How we source info

The severity of nausea can vary depending on the person

Bathroom cabinets, loose long-term pill organizers, and unmarked travel containers can make identification harder and may expose tablets to poor storage conditions

45.Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized trials

Meta-analysis of head-to-head clinical trials comparing incretin-based glucose-lowering medications and basal insulin: an update including recently developed glucagon-like peptide-1 (GLP-1) receptor agonists and the glucose-dependent insulinotropic polypeptide/GLP-1 receptor co-agonist tirzepatide